2023 Vol.41, N°11 - Table of contents
November 2023
One year in review
CER16723
2023,41,11
Pg. 2129-2141
Free to view
Novel insights into the management of rheumatoid arthritis: one year in review 2023
C. Garaffoni, A. Adinolfi, A. Bortoluzzi, G. Filippou, A. Giollo, G. Sakellariou, E. Silvagni, S. Sirotti, N. Ughi, C.A. Scirè
DOI: https://doi.org/10.55563/clinexprheumatol/nat8nl
C. Garaffoni, A. Adinolfi, A. Bortoluzzi, G. Filippou, A. Giollo, G. Sakellariou, E. Silvagni, S. Sirotti, N. Ughi, C.A. Scirè
DOI: https://doi.org/10.55563/clinexprheumatol/nat8nl
CER17273
2023,41,11
Pg. 2142-2150
Free to view
Axial spondyloarthritis: one year in review 2023
F. Fattorini, S. Gentileschi, C. Cigolini, R. Terenzi, A.P. Pata, L. Esti, L. Carli
DOI: https://doi.org/10.55563/clinexprheumatol/9fhz98
F. Fattorini, S. Gentileschi, C. Cigolini, R. Terenzi, A.P. Pata, L. Esti, L. Carli
DOI: https://doi.org/10.55563/clinexprheumatol/9fhz98
Full Papers
CER16340
2023,41,11
Pg. 2151-2161
Free to view
Interleukin-13 reduces bone erosion in rheumatoid arthritis by up-regulating osteoprotegerin expression in fibroblast-like synoviocytes : an in vitro and in vivo study
Z. Chen, Z. Cheng, Z. Tang, M. Li, X. Tang, H. Zhang, L. Sun
DOI: https://doi.org/10.55563/clinexprheumatol/b96n1e
Z. Chen, Z. Cheng, Z. Tang, M. Li, X. Tang, H. Zhang, L. Sun
DOI: https://doi.org/10.55563/clinexprheumatol/b96n1e
CER16394
2023,41,11
Pg. 2162-2166
Free to view
Impact of disease duration on proteomic bioprofile and prognosis in rheumatoid arthritis patients
M. Brandão, T. Fonseca, R. Quelhas Costa, J.C. Oliveira, H. Cyrne Carvalho, P. Rodrigues, F. Zannad, P. Rossignol, M.B. Ferreira, J.P. Ferreira
DOI: https://doi.org/10.55563/clinexprheumatol/ua087b
M. Brandão, T. Fonseca, R. Quelhas Costa, J.C. Oliveira, H. Cyrne Carvalho, P. Rodrigues, F. Zannad, P. Rossignol, M.B. Ferreira, J.P. Ferreira
DOI: https://doi.org/10.55563/clinexprheumatol/ua087b
CER16117
2023,41,11
Pg. 2167-2176
High-throughput RNA-sequencing reveals novel targets of tofacitinib in the treatment of rheumatoid arthritis
Q. Chen, Q. Geng, X. Yu, F. Lu, J. Li, H. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/g2v2ae
Q. Chen, Q. Geng, X. Yu, F. Lu, J. Li, H. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/g2v2ae
CER16359
2023,41,11
Pg. 2177-2181
Free to view
Disease burden measured by patient-reported outcomes: does psoriatic arthritis feel worse than rheumatoid arthritis? A cross-sectional nationwide study
L. Weman, H. Salo, L. Kuusalo, J. Huhtakangas, P. Vähäsalo, M. Backström, J. Kärki, T. Sokka-Isler
DOI: https://doi.org/10.55563/clinexprheumatol/h9hn90
L. Weman, H. Salo, L. Kuusalo, J. Huhtakangas, P. Vähäsalo, M. Backström, J. Kärki, T. Sokka-Isler
DOI: https://doi.org/10.55563/clinexprheumatol/h9hn90
CER16404
2023,41,11
Pg. 2182-2191
FXR1 impedes the development of osteoarthritis by targeting SND1
H. Wang, Z. Li, L. Chen, H. Lv, Y. Sun, F. Yan, Y. Lu
DOI: https://doi.org/10.55563/clinexprheumatol/2z9o11
H. Wang, Z. Li, L. Chen, H. Lv, Y. Sun, F. Yan, Y. Lu
DOI: https://doi.org/10.55563/clinexprheumatol/2z9o11
CER16397
2023,41,11
Pg. 2192-2199
Higher skin autofluorescence in individuals at risk for rheumatoid arthritis: results from a large population-based cohort
H.J. Hinkema, S. Arends, D.J. Mulder, J. Westra, E. Brouwer
DOI: https://doi.org/10.55563/clinexprheumatol/6aan1g
H.J. Hinkema, S. Arends, D.J. Mulder, J. Westra, E. Brouwer
DOI: https://doi.org/10.55563/clinexprheumatol/6aan1g
CER16460
2023,41,11
Pg. 2200-2206
Serological markers of basement membrane collagen type IV and laminin are increased in systemic lupus erythematosus but differentially expressed in patients with previous cardiovascular events
F. Genovese, S. Due Kay, M.A. Karsdal, A. Voss, P. Junker
DOI: https://doi.org/10.55563/clinexprheumatol/1rm7nm
F. Genovese, S. Due Kay, M.A. Karsdal, A. Voss, P. Junker
DOI: https://doi.org/10.55563/clinexprheumatol/1rm7nm
CER16433
2023,41,11
Pg. 2207-2215
Free to view
Interleukin-18 binding protein regulates the apoptosis and necroptosis of fibroblast-like synoviocytes and chondrocytes in rheumatoid arthritis
H.K. Min, S.H. Kim, J.-Y. Lee, S.-H. Lee, H.-R. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/hjvvf1
H.K. Min, S.H. Kim, J.-Y. Lee, S.-H. Lee, H.-R. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/hjvvf1
CER16344
2023,41,11
Pg. 2216-2223
Free to view
Characterisation of T and B cell receptor repertoire in patients with systemic lupus erythematosus
X. Hou, W. Wei, J. Zhang, Z. Liu, G. Wang, X. Yang, Y. Dai
DOI: https://doi.org/10.55563/clinexprheumatol/1rjr4s
X. Hou, W. Wei, J. Zhang, Z. Liu, G. Wang, X. Yang, Y. Dai
DOI: https://doi.org/10.55563/clinexprheumatol/1rjr4s
CER16555
2023,41,11
Pg. 2224-2229
DAS28(3)CRP is a reliable measure of disease activity in pregnant women with rheumatoid arthritis
C. Raine, C. Ciurtin, E.C. Jury, D.J. Williams, D. Bennett, J.J. Manson, I. Giles
DOI: https://doi.org/10.55563/clinexprheumatol/mf9dxk
C. Raine, C. Ciurtin, E.C. Jury, D.J. Williams, D. Bennett, J.J. Manson, I. Giles
DOI: https://doi.org/10.55563/clinexprheumatol/mf9dxk
CER16421
2023,41,11
Pg. 2230-2238
Free to view
Hydroxychloroquine exposure reduces the risk of cardiovasular disease events in patients with hypertension or diabetes mellitus
C.-H. Chen, H.-A. Chen, H.-T. Liao, C.-H. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/y7psev
C.-H. Chen, H.-A. Chen, H.-T. Liao, C.-H. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/y7psev
CER16566
2023,41,11
Pg. 2239-2248
Association of polycyclic aromatic hydrocarbons with osteoarthritis among adults: an analysis of the NHANES 2001-2016
Z. Lu, Y. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/6xjdfn
Z. Lu, Y. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/6xjdfn
CER16425
2023,41,11
Pg. 2249-2256
Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative
P.S. Akhavan, M. Movahedi, A. Cesta, C. Bombardier
and other OBRI investigators
DOI: https://doi.org/10.55563/clinexprheumatol/r7b8go
P.S. Akhavan, M. Movahedi, A. Cesta, C. Bombardier
and other OBRI investigators
DOI: https://doi.org/10.55563/clinexprheumatol/r7b8go
CER16374
2023,41,11
Pg. 2257-2263
Free to view
Clinical and prognostic features associated with anti-Ro52 autoantibodies in connective tissue diseases patients with interstitial lung disease
X. Shi, X. Pu, D. Cao, T. Yan, Q. Ye
DOI: https://doi.org/10.55563/clinexprheumatol/ntluzy
X. Shi, X. Pu, D. Cao, T. Yan, Q. Ye
DOI: https://doi.org/10.55563/clinexprheumatol/ntluzy
CER16440
2023,41,11
Pg. 2264-2268
Absolute risk estimation of new-onset proteinuria in patients with systemic lupus erythematosus: a Danish nationwide cohort study
M. Andersen, A. Stockmarr, H.C. Leffers, A. Troldborg, A. Voss, S. Kristensen, B. Deleuran, L. Dreyer, L. Johnsen, A. Colic, S. Jacobsen
DOI: https://doi.org/10.55563/clinexprheumatol/rk2dxp
M. Andersen, A. Stockmarr, H.C. Leffers, A. Troldborg, A. Voss, S. Kristensen, B. Deleuran, L. Dreyer, L. Johnsen, A. Colic, S. Jacobsen
DOI: https://doi.org/10.55563/clinexprheumatol/rk2dxp
CER16505
2023,41,11
Pg. 2269-2276
Free to view
Sleep quality and predictors of optimal sleep in patients with rheumatoid arthritis: data from a recent-onset cohort
G.A. Guaracha-Basáñez, I. Contreras-Yáñez, L.E. Bautista-Torres, A.B. Ortiz-Haro, V. Pascual-Ramos
DOI: https://doi.org/10.55563/clinexprheumatol/j88k7a
G.A. Guaracha-Basáñez, I. Contreras-Yáñez, L.E. Bautista-Torres, A.B. Ortiz-Haro, V. Pascual-Ramos
DOI: https://doi.org/10.55563/clinexprheumatol/j88k7a
CER16545
2023,41,11
Pg. 2277-2285
An Italian nationwide survey on the evolution of autoantibody diagnostics in autoimmune rheumatic diseases
T. Carbone, M. Infantino, A. Antico, B. Porcelli, D. Villalta, V. Pafundi, N. Bizzaro
DOI: https://doi.org/10.55563/clinexprheumatol/bhnk4l
T. Carbone, M. Infantino, A. Antico, B. Porcelli, D. Villalta, V. Pafundi, N. Bizzaro
DOI: https://doi.org/10.55563/clinexprheumatol/bhnk4l
CER16619
2023,41,11
Pg. 2286-2297
Free to view
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study
P. Mease, A. Setty, K. Papp, F. Van Den Bosch, S. Tsuji, M. Keiserman, K. Carter, Y. Li, R. Mccaskill, E. Mcdearmon-Blondell, P. Wung, W. Tillett
DOI: https://doi.org/10.55563/clinexprheumatol/8l7bbk
P. Mease, A. Setty, K. Papp, F. Van Den Bosch, S. Tsuji, M. Keiserman, K. Carter, Y. Li, R. Mccaskill, E. Mcdearmon-Blondell, P. Wung, W. Tillett
DOI: https://doi.org/10.55563/clinexprheumatol/8l7bbk
Brief Paper
CER16549
2023,41,11
Pg. 2298-2300
Free to view
Role of Patrick-FABER test in detecting sacroiliitis and diagnosing spondyloarthritis in subjects with low back pain
M. Tasso, V. Uguccioni, N. Bertolini, A. Bernasconi, M. Mariconda, R. Scarpa, L. Costa, F. Caso
DOI: https://doi.org/10.55563/clinexprheumatol/kgje8k
M. Tasso, V. Uguccioni, N. Bertolini, A. Bernasconi, M. Mariconda, R. Scarpa, L. Costa, F. Caso
DOI: https://doi.org/10.55563/clinexprheumatol/kgje8k
Reviews
CER16621
2023,41,11
Pg. 2301-2311
Free to view
The prevalence of pulmonary arterial hypertension in patients with mixed connective tissue disease: a systematic review and meta-analysis
A.B. Hassan, R.F. Hozayen, Z.S. Mustafa, I.E. Lundberg, H.A. Jahrami
DOI: https://doi.org/10.55563/clinexprheumatol/srma43
A.B. Hassan, R.F. Hozayen, Z.S. Mustafa, I.E. Lundberg, H.A. Jahrami
DOI: https://doi.org/10.55563/clinexprheumatol/srma43
CER16717
2023,41,11
Pg. 2312-2322
Free to view
Primary aldosteronism: an unsuspected culprit of hypertension in systemic lupus erythematosus?
G.S. Feng, J.R. Kent, P.J. Fuller, A.Y. Hoi, A.R. Kitching, J. Yang, F.B. Vincent
DOI: https://doi.org/10.55563/clinexprheumatol/h58aqe
G.S. Feng, J.R. Kent, P.J. Fuller, A.Y. Hoi, A.R. Kitching, J. Yang, F.B. Vincent
DOI: https://doi.org/10.55563/clinexprheumatol/h58aqe
Paediatric Rheumatology
CER16539
2023,41,11
Pg. 2323-2330
Free to view
Pharmacodynamics of rituximab in paediatric immune mediated diseases: B cell depletion and repopulation, effects on immunoglobulin levels and risk for infections
A. Nassar-Sheikh rashid, S.C. Bergkamp, R.E. Kampinga, S.C. Gouw, A.H. Bouts, M.J. Oosterveld, P.A. Baars, E.M. Van Leeuwen, T.W. Kuijpers, J.M. Van Den Berg, D. Schonenberg-Meinema
DOI: https://doi.org/10.55563/clinexprheumatol/yqjz1s
A. Nassar-Sheikh rashid, S.C. Bergkamp, R.E. Kampinga, S.C. Gouw, A.H. Bouts, M.J. Oosterveld, P.A. Baars, E.M. Van Leeuwen, T.W. Kuijpers, J.M. Van Den Berg, D. Schonenberg-Meinema
DOI: https://doi.org/10.55563/clinexprheumatol/yqjz1s
CER16662
2023,41,11
Pg. 2331-2337
Haematological and other manifestations in the presence of antiphospholipid antibodies in a multicentric paediatric cohort
P. Morán Álvarez, Á. Andreu-Suárez, L. Caballero-Mota, S. Gassiot-Riu, R. Berrueco-Moreno, J. Calzada-Hernández, M. Vázquez-Díaz, A. Boteanu, V. Messia, L. Giovannelli, F. De Benedetti, J. Antón-López, C. Bracaglia
DOI: https://doi.org/10.55563/clinexprheumatol/3mzh06
P. Morán Álvarez, Á. Andreu-Suárez, L. Caballero-Mota, S. Gassiot-Riu, R. Berrueco-Moreno, J. Calzada-Hernández, M. Vázquez-Díaz, A. Boteanu, V. Messia, L. Giovannelli, F. De Benedetti, J. Antón-López, C. Bracaglia
DOI: https://doi.org/10.55563/clinexprheumatol/3mzh06
Letters to the Editor
CER16679
2023,41,11
Pg. 2338
Free to view
Chronic chilblain-like lesions occurring during the Covid pandemic: case series
J. Nathan, A. Rastogi, P.D. Kiely
DOI: https://doi.org/10.55563/clinexprheumatol/yc0v8a
J. Nathan, A. Rastogi, P.D. Kiely
DOI: https://doi.org/10.55563/clinexprheumatol/yc0v8a
CER16690
2023,41,11
Pg. 2339-2340
Free to view
Baricitinib for systemic lupus erythematosus: not enough, or not enough evidence?
D. Patoulias, A. Dimosiari, T. Dimitroulas
DOI: https://doi.org/10.55563/clinexprheumatol/0of42a
D. Patoulias, A. Dimosiari, T. Dimitroulas
DOI: https://doi.org/10.55563/clinexprheumatol/0of42a
CER16735
2023,41,11
Pg. 2341
Free to view
Comment on the paper by Kapsala et al.
G.S. Alarcón, B.A. Pons-Estel, G.J. Pons-Estel, E. Zavala, R. Nieto, R. Quintana
DOI: https://doi.org/10.55563/clinexprheumatol/tz7trd
G.S. Alarcón, B.A. Pons-Estel, G.J. Pons-Estel, E. Zavala, R. Nieto, R. Quintana
DOI: https://doi.org/10.55563/clinexprheumatol/tz7trd
CER16860
2023,41,11
Pg. 2342
Free to view
Reply to the comment by Alarcón et al.
N. Kapsala, A. Fanouriakis, D.T. Boumpas
DOI: https://doi.org/10.55563/clinexprheumatol/fphklo
N. Kapsala, A. Fanouriakis, D.T. Boumpas
DOI: https://doi.org/10.55563/clinexprheumatol/fphklo